Staining by anti-Cytokeratin 19 Antibody 1

Anti-Cytokeratin 19 Antibody Clone A53-B/A2.26 + BA17

$ 429.00
Please Select Product Options Below To View The Catalog Number.

SKU: 3880-MSM3
Species: Human
Tested Applications: Flow Cytometry, Immunofluorescence, Immunohistochemistry (IHC)
Available Conjugates: Unconjugated
Isotype: Mouse IgG1 IgG2a kappa
Mass Spec Validated?: Not MS Validated

Product NumberDescriptionPrice
3880-MSM3-P1 Size: 100 ug, Tag: Unconjugated
Shipping Information
In Stock.
Flat Rate Shipping Anywhere in the US: $45
Datasheets and Documentation
Product Datasheet
Certificate of Analysis and Tags (Coming Soon)
Lot Number:

Expiration Date:

Concentration (Write Lyophilized if Lyophilized):

Reconsitution Instructions (Leave Blank if Liquid):

Manufacture Date:

Purity:

Bioactivity (test results eg. IU/ml):


SKU: 3880-MSM3-P1
Cytokeratin 19 General Information
Alternate Names
Keratin, type I cytoskeletal 19, cytokeratin-19, CK-19, keratin-19, K19, KRT19
Molecular Weight
40kDa
Chromosomal Location
17q21.2
Curated Database and Bioinformatic Data
Gene SymbolKRT19
Entrez Gene ID3880
Ensemble Gene IDENSG00000171345
RefSeq Protein Accession(s)NP_002267
RefSeq mRNA Accession(s)NM_002276
RefSeq Genomic Accession(s)NC_000017, NC_018928, NG_012285
UniProt ID(s)P08727
UniGene ID(s)P08727
HGNC ID(s)6436
Cosmic ID(s)KRT19
KEGG Gene ID(s)hsa:3880
PharmGKB ID(s)PA30225
General Description of Cytokeratin 19.
This MAb reacts with the rod domain of human cytokeratin-19 (CK19), a polypeptide of 40kDa. CK19 is expressed in sweat gland, mammary gland ductal, secretory cells, bile ducts, gastrointestinal tract, bladder urothelium, oral epithelia, esophagus,, ectocervical epithelium. Anti-CK19 reacts with a wide variety of epithelial malignancies including adenocarcinomas of the colon, stomach, pancreas, biliary tract, liver,, breast. Perhaps the most useful application is the identification of thyroid carcinoma of the papillary type, although 50%-60% of follicular carcinomas are also labeled. Anti-CK19 is a useful marker for detection of tumor cells in lymph nodes, peripheral blood, bone marrow, breast cancer.

Human Anti-Cytokeratin 19 Antibody Product Attributes

Species: Human
Tested Applications: Flow Cytometry, Immunofluorescence, Immunohistochemistry (IHC).
Application Notes: Flow Cytometry (0.5-1ug of antibody/million cells in 0.1ml), Immunofluorescence (1-2ug of antibody/ml), Immunohistochemistry (IHC) (Formalin-fixed) (0.5-1ug of antibody/ml for 30 min at RT)
Clonality: Monoclonal
Anti-Cytokeratin 19 Antibody Clone: A53-B/A2.26 + BA17
Clone A53-B/A2.26 + BA17 Host and Isotype: Mouse IgG1 IgG2a kappa
Anti-Human Cytokeratin 19 Positive Control Sample: MCF-7, HeLa, Hep-G2 cells, Breast Cancer
Cellular Localization of Antibody Cytoplasmic
Buffer and Stabilizer: 10mM PBS with 0.05% BSA & 0.05% azide.
Antibody Concentration: 200ug/ml
Antibody Purification Method:Protein A/G Purified
Immunogen: Human breast cancer MCF-7 cells (A53-B/A2); Human mammary epithelial organoids (BA17)
Storage Conditions: Store at 2 to 8° C (refrigerate). Stable for 24 months when properly stored.

Cytokeratin 19 Previously Observed Antibody Staining Patterns

Observed Subcellular, Organelle Specific Staining Data:

Anti-KRT19 antibody staining is expected to be primarily localized to the intermediate filaments. There is variability in either the signal strength or the localization of signal in intermediate filaments from cell to cell.

Observed Antibody Staining Data By Tissue Type:

Variations in Cytokeratin 19 antibody staining intensity in immunohistochemistry on tissue sections are present across different anatomical locations. An intense signal was observed in bile duct cells in the liver, cells in the tubules in kidney, exocrine glandular cells in the pancreas, glandular cells in the appendix, breast, cervix, uterine, colon, duodenum, endometrium, epididymis, fallopian tube, gallbladder, prostate, rectum, salivary gland, seminal vesicle, small intestine, stomach and thyroid gland, pneumocytes in lung, respiratory epithelial cells in the bronchus and nasopharynx, squamous epithelial cells in the tonsil, trophoblastic cells in the placenta and urothelial cells in the urinary bladder. More moderate antibody staining intensity was present in bile duct cells in the liver, cells in the tubules in kidney, exocrine glandular cells in the pancreas, glandular cells in the appendix, breast, cervix, uterine, colon, duodenum, endometrium, epididymis, fallopian tube, gallbladder, prostate, rectum, salivary gland, seminal vesicle, small intestine, stomach and thyroid gland, pneumocytes in lung, respiratory epithelial cells in the bronchus and nasopharynx, squamous epithelial cells in the tonsil, trophoblastic cells in the placenta and urothelial cells in the urinary bladder. Low, but measureable presence of Cytokeratin 19 could be seen inepidermal cells in the skin, squamous epithelial cells in the cervix and uterine and oral mucosa. We were unable to detect Cytokeratin 19 in other tissues. Disease states, inflammation, and other physiological changes can have a substantial impact on antibody staining patterns. These measurements were all taken in tissues deemed normal or from patients without known disease.

Observed Antibody Staining Data By Tissue Disease Status:

Tissues from cancer patients, for instance, have their own distinct pattern of Cytokeratin 19 expression as measured by anti-Cytokeratin 19 antibody immunohistochemical staining. The average level of expression by tumor is summarized in the table below. The variability row represents patient to patient variability in IHC staining.

Sample Type breast cancer carcinoid cervical cancer colorectal cancer endometrial cancer glioma head and neck cancer liver cancer lung cancer lymphoma melanoma ovarian cancer pancreatic cancer prostate cancer renal cancer skin cancer stomach cancer testicular cancer thyroid cancer urothelial cancer
Signal Intensity +++ +++ +++ +++ +++ - + - +++ - - +++ +++ +++ + ++ +++ - +++ +++
KRT19 Variability + + + + + + ++ ++ + + + + + ++ +++ ++ + + ++ +

Limitations and Warranty

enQuire Bio's Cytokeratin 19 Anti-Human Monoclonal is available for Research Use Only. This antibody is guaranteed to work for a period of two years when properly stored.

There are no reviews yet.

Be the first to review “Anti-Cytokeratin 19 Antibody Clone A53-B/A2.26 + BA17”

Your email address will not be published. Required fields are marked *

Share a Protocol (View Reviewed Protocols Below)

Protocol Title

Materials

Methods

Notes


  protocol submission gif
enQuire Bio, LLC   8420 S Continental Divide Rd, #202   Littleton, CO 80127
Chat: See lower right corner. | enquire@enquirebio.com | Fax: 1-720-897-3730
Customer Service Available M-F 8AM-6PM MST or 24/7 Via Email

Anti-Cytokeratin 19 Antibody Clone A53-B/A2.26 + BA17